Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
chronic kidney disease
Pharma
GSK's anemia drug Jesduvroq scores FDA green light
The FDA approved the drug for patients who are on dialysis. Safety in the non-dialysis patient population "has not been established," the agency said.
Zoey Becker
Feb 2, 2023 8:30am
AZ targets people who don't know they have CKD in new spot
Jan 27, 2023 7:30am
Unicycive's pivotal trial of Takeda kidney drug rival hits goal
Jan 3, 2023 7:30am
Travere teams up with patient groups for new kidney campaign
Nov 21, 2022 7:55am
After pair of losses, Ardelyx's CKD prospect finds FDA foothold
Nov 17, 2022 8:05am
FDA flags concerns about Ardelyx's kidney disease prospect
Nov 15, 2022 10:48am